Please login to the form below

Not currently logged in
Email:
Password:

Dr Martine Dehlinger-Kremer becomes EUCROF president

She brings experience from SynteractHCR

EUCROF Dr Martine Delinger-KremerThe European Contract Research Organisation Foundation (EUCROF) has elected Dr Martine Dehlinger-Kremer as its president.

Representing over 300 CROs across Europe, Dr Dehlinger-Kremer will be responsible for developing the foundation's educational activities and overseeing its plans for expansion. She will continue to serve as chair of the EUCROF Paediatric Working Group, having held the post since 2008.

Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.

She was recently appointed chair of the European Forum for Good Clinical Practice Children's Medicines Working Party, and has been a member of the EMA's working groups, Paediatric Network since 2013.

Wendel Barr, chief executive of SynteractHCR, said: “Dr. Dehlinger-Kremer has shown her commitment to advancing clinical research throughout her career.

“She exemplifies our mission at SynteractHCR of developing a better future for patients by bringing expertise to clinical development - and this additional position at EUCROF furthers that goal.

“We congratulate her on this honour and recognition of her expertise.”

20th December 2016

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics